Bio-Rad Laboratories, Inc.
NYSE: BIO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Norman D. Schwartz
- Employees
- 7,700
- Headquarters
- Hercules, United States
- IPO year
- 1980
- Market cap
- $7.6B
- Website
- https://www.bio-rad.com
Loading BIO…
Loading profile data…Frequently asked questions about BIO
What does Bio-Rad Laboratories, Inc. (BIO) do?
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical D...
Where does BIO trade?
Bio-Rad Laboratories, Inc. (BIO) trades on the New York Stock Exchange.
What sector is BIO in?
Bio-Rad Laboratories, Inc. (BIO) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Bio-Rad Laboratories, Inc.?
Norman D. Schwartz is the chief executive officer of Bio-Rad Laboratories, Inc. (BIO).
Where is Bio-Rad Laboratories, Inc. headquartered?
Bio-Rad Laboratories, Inc. is headquartered in United States.
Does BIO pay a dividend?
Bio-Rad Laboratories, Inc. (BIO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BIO go public?
Bio-Rad Laboratories, Inc. (BIO) completed its initial public offering in 1980.